Understanding and exploiting bioactivation enzymes in Mycobacterium tuberculosis as a non-canonical anti-TB strategy
Dimitri Leonelli(Centre National de la Recherche Scientifique), Hédia Marrakchi(Centre National de la Recherche Scientifique), Nicolas Tomas(Centre National de la Recherche Scientifique), Sylvain Marthev, Mamadou Daffé(Centre National de la Recherche Scientifique), Véronique Martin(UK Health Security Agency), Gwenaëlle André-Leroux(Université Paris-Saclay), Anne Lemassu(Centre National de la Recherche Scientifique)
HAL (Le Centre pour la Communication Scientifique Directe)
September 22, 2021
Cited by 0
Related Papers
The complete genome sequence of the meat-borne lactic acid bacterium Lactobacillus sakei 23K
|Nature Biotechnology|2005|391
Direct Visualization by Cryo-EM of the Mycobacterial Capsular Layer: A Labile Structure Containing ESX-1-Secreted Proteins
|PLoS Pathogens|2010|306
Systematic longitudinal survey of invasive <i>Escherichia coli</i> in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131
|Genome Research|2017|300
The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections
|Intensive Care Medicine|2017|149